Evidence map›Paper›PMID 24924657›Full record

ArticleSleep medicine2014

The association between sleep characteristics and prothrombotic markers in a population-based sample: Chicago Area Sleep Study.

Zehra Tosur, David Green, Peter John De Chavez, Kristen L Knutson, Jeffrey J Goldberger, Phyllis Zee, Kiang Liu, Kwang-Youn Kim, Mercedes R Carnethon

Open access · greenAbstract read
In one paragraph

Article in Sleep medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2017
    Observational
  8. Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence.Arteriosclerosis, thrombosis, and vascular biology · 2017
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zehra TosurDivision of Hematology/Oncology, Department of Medicine, Chicago, IL, USA.
David GreenDivision of Hematology/Oncology, Department of Medicine, Chicago, IL, USA.
Peter John De ChavezDepartment of Preventive Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.
Kristen L KnutsonDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Jeffrey J GoldbergerDepartment of Preventive Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.
Phyllis ZeeDepartment of Preventive Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.
Kiang LiuDepartment of Preventive Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.
Kwang-Youn KimDepartment of Preventive Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.
Mercedes R CarnethonDepartment of Preventive Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA. Electronic address: carnethon@northwestern.edu.
Northwestern University · USUniversity of Chicago Medical Center · USUniversity of Chicago · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Research Design, Data, and Analytics CoreP30DK092949 · NIDDK · UNIVERSITY OF CHICAGO · PI MILDA Renne SAUNDERS · 2011 to 2026
$10.0M
Autonomic, Endothelial, and Inflammatory Correlates of Sleep DurationR01HL092140 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CARNETHON, MERCEDES RENEE · 2009 to 2012
$2.0M
NCATS NIH HHS UL1 TR000430NHLBI NIH HHS R01 HL092140NHLBI NIH HHS R01HL092140NIDDK NIH HHS P30 DK092949
6 · The paper itself

Abstract

BACKGROUND AND

aimShort sleep duration and poor quality sleep are associated with coronary heart disease (CHD) mortality; however, the underlying pathophysiologic process remains unclear. Sleep apnea may confound the association because of its relationship with formation of thrombi, the vascular occlusive process in CHD. We tested whether sleep duration and quality were associated with prothrombotic biomarkers in adults with a low probability of apnea.

methodsWe included adults aged 35-64 years recruited from the community and who had an apnea hypopnea index <15 after one night of screening (n=506). Sleep duration and maintenance were determined from 7 days of wrist actigraphy; daytime sleepiness was estimated using the Epworth Sleepiness Scale. Factor VIII (FVIII), von Willebrand factor (vWF), thrombin antithrombin (TAT) complexes, and plasminogen activator inhibitor-1 (PAI-1) were measured in fasting blood.

resultsSleep duration, maintenance, and daytime sleepiness were not associated with FVIII, vWf, or TAT. Sleep maintenance was modestly inversely associated with higher levels of log-transformed PAI-1 (β = -0.07, standard error (SE)=0.03 per 4.8%, p=0.04) following adjustment for demographic characteristics, cardiovascular risk factors, and body mass index (BMI).

conclusionsMild impairment in sleep was modestly associated with activation of coagulation; further study is needed to evaluate the role of fibrinolytic factors in sleep-mediated coronary thrombosis.

Indexed as

ActigraphyAdultAntithrombin IIIBiomarkersCross-Sectional StudiesFactor VIIIFemaleHumansMaleMiddle AgedPeptide HydrolasesPlasminogen Activator Inhibitor 1SleepSleep DeprivationSleep Wake DisordersSurveys and QuestionnairesAntithrombin IIIantithrombin III-protease complexBiomarkersFactor VIIIPeptide HydrolasesPlasminogen Activator Inhibitor 1von Willebrand FactorCardiovascular diseaseHemostatic factorsPopulation studiesProcoagulantsSleep apneaSleep duration

Identifiers

PMID24924657
PMCPMC4117713
OpenAlexW2055743740

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.